Proactive Investors - Run By Investors For Investors

THC Global shares rise after securing cannabis permits from the Office of Drug Control

This is an important milestone towards full-scale medicinal cannabis production in Australia.
cannabis leaves
THC shares are trading about 6% higher intra-day, at 46 cents

THC Global Group Ltd’s (ASX:THC) wholly owned subsidiary Canndeo has received two Cannabis Permits from the Office of Drug Control (ODC) allowing the cultivation and production of THC’s proprietary high CBD (cannabidiol) strains at its Queensland growing and R&D facility.

The granting of these permits represents the next step in THC’s farm-to-pharma medicinal cannabis strategy as the company builds up cannabis plant supply for processing into cannabis oils and other medicinal cannabis products at its Australian manufacturing facility.

READ: THC Global Group completes name change from The Hydroponics Company Ltd

Further, the data gained through the research under the permits will assist in optimising yields and quality as THC pursues full-scale cultivation at its Australian growing facilities.

In addition to the permits granted by the ODC, THC has two separate manufacturing licence applications under review over two sites being the now ODC permitted growing and R&D facility, and the company’s large-scale manufacturing facility.

READ: The Hydroponics Company well placed to grow as Canada set to legalise recreational cannabis

THC chief executive officer Ken Charteris said: “The receipt of these permits is a critical step in progressing our Australian farm-to-pharma strategy and confirms expectations that THC Global will be in a position to commence full-scale production in the near term as one of the only Australian companies to have production ready facilities with licencing and permitting at an advanced stage.

“We also look forward to engaging our global commercial partners in further research and development activities on our proprietary strains as we seek to commercialise these assets in the near term.”

READ: THC Global to exclusively import CBD products into New Zealand

The successful granting of the permits provides security that THC’s operations, personnel, and procedures are acceptable to the ODC for a cannabis producing entity.

THC is in a unique position compared to almost all other participants in the domestic cannabis sector as it has fully built, production-ready facilities submitted for licencing and permitting that are able to be physically inspected by the ODC rather than seeking licencing for projects in the pre-construction phase that have multi-year build out.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full THC profile View Profile

THC Global Group Ltd Timeline

Related Articles

cannabis plan in sun
February 21 2019
The cannabis company will manufacture, infuse and package branded recreational and wellness products
The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 30 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth
A cannabis plant shown next to an oil-based product
March 04 2019
THC is developing its medicinal cannabis strategy in Australia, New Zealand and Canada and is looking to Asian markets.

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use